Helper T Cells, a crucial component of the immune system, are a subset of T lymphocytes that play a central role in orchestrating and regulating immune responses. These cells express the CD4 surface marker and are involved in coordinating the activities of other immune cells, hence their name "helper." Upon encountering antigens presented by antigen-presenting cells, helper T cells become activated and undergo clonal expansion. They release signaling molecules, such as cytokines, that direct and enhance the immune response. Helper T cells are categorized into two main types: Th1 cells, which promote cellular immunity and are involved in defense against intracellular pathogens, and Th2 cells, which stimulate antibody production and aid in the elimination of extracellular parasites. Helper T cells are pivotal in activating cytotoxic T cells, B cells, and macrophages, coordinating both the cellular and humoral arms of the immune system. Dysfunction in helper T cell regulation can lead to autoimmune diseases, allergies, or immunodeficiency disorders. The discovery of helper T cells and their role in immune regulation has significantly influenced vaccine development, transplantation medicine, and our understanding of infectious diseases. Ongoing research continues to unveil the complexities of helper T cell biology, offering insights into novel therapeutic strategies for various immune-related disorders.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Will be updated soon...
Vasiliki E Kalodimou, European University-Cyprus Ltd, Cyprus
Title : Will be updated soon...
Nagy Habib, Imperial College London, United Kingdom
Title : Will be updated soon...
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : Advanced 3D tissue models: Pioneering tools for investigating health and disease
Lucie Bacakova, Institute of Physiology of the Czech Academy of Sciences, Czech Republic
Title : Developing iPSC-derived 3D Outer Blood-Retinal Barrier Disease Models of Choroideremia for Gene Therapy Evaluation
Aradhana Kasimsetty, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), United States